Remove Blogging Remove Invest Remove San Diego Remove Startup

Podcast: How San Diego is Building a Biotech Ecosystem – Genomics & Precision Medicine Experts Weigh in

Xconomy

Our new podcast packages the highlights from the recent Xcelerating Life Sciences San Diego: Biomedical Breakthroughs in Precision Medicine & Genomics forum. How has the investment paradigm shift in funding strategies impacted San Diego?

33 Tech Startups Make San Diego Venture Group “Cool Companies” List

Xconomy

What does it take for a tech startup to be considered “cool?” In the eyes of the San Diego Venture Group, the key element is readiness for venture capital backing.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

San Diego Tech Roundup: Ezoic, Trust & Will, Oska Wellness & More

Xconomy

Summer can be a slow time in San Diego, but its startups have stayed busy. —Ezoic, a startup that developed software for web publishers that uses machine learning techniques to personalize layouts and ad placements for site visitors, raised $33 million to further develop its technology. Sageview Capital, an investment firm with offices in Palo Alto, CA, and in Greenwich, CT, was the lone investor that participated in the deal.

San Diego Startup Raises $2.3M to Advance Enzymatic DNA Synthesis

Xconomy

Molecular Assemblies , a San Diego startup developing a new enzymatic method for synthesizing DNA, said today it has raised $2.3 million in a seed financing round.

Uber Rejiggers App to Highlight Its Bikes, Scooters in San Diego

Xconomy

San Diego is one of two metropolitan areas in which ride-hailing giant Uber has reformatted its mobile app to make it simpler for users to rent an electric bicycle or scooter.

$100M Round Turns San Diego’s Seismic into Region’s Newest Unicorn

Xconomy

The venture investment, which the San Diego startup announced Tuesday, is one of only a few so-called mega-rounds—$100 million or more—recorded this year in the region. (In Seismic, an enterprise software company with ambitious growth plans, has raised $100 million in a Series E financing and added Microsoft chairman John W. Thompson to its board of directors.

Why Comma.ai, Maker of Self-Driving Tech, is Moving to San Diego

Xconomy

San Diego’s startup community has rejoiced in recent months as massive companies that employ thousands of engineers—including Amazon (NASDAQ: AMZN ), Apple (NASDAQ: AAPL ), and the tech arm of Walmart (NYSE: WMT )—have announced expansions in the region. Local entrepreneurs hope that investment will make other tech businesses, including early-stage companies, more comfortable settling in the region, where concerns about talent recruitment are long-standing.

Plug and Play San Diego Finds Home in New Downtown Works Space

Xconomy

Plug and Play San Diego has formed a partnership with Downtown Works, a new co-working space in downtown San Diego, which will give the local Plug and Play program a place to call home.

Xconomy Guide to Best Sessions at Startup Week San Diego

Xconomy

Startup Week San Diego, like a lot of other places that host similar events, has been billed as a weeklong celebration of entrepreneurship. Seattle’s UP Global, now part of Techstars, oversees the operation of Startup Week and other programs for tech entrepreneurs across the U.S.

Walmart: Turning San Diego Into A Key Technology Center

socalTECH

However, the company's technology team, Walmart Labs (www.walmartlabs.com)--which said this month that it is planning on major growth in San Diego is responsible for the company's key supply chain technology, online e-commerce site, and much more. We caught up with Claude Jones , who is in charge of growing Walmart's technology team in Carlsbad from 70 people and tripling the team, out of new offices it announced this month. How long has Walmart had an office in San Diego?

Walmart: Turning San Diego Into Its Technology Center

socalTECH

However, the company's technology team, Walmart Labs (www.walmartlabs.com)--which said this month that it is planning on major growth in San Diego is responsible for the company's key supply chain technology, online e-commerce site, and much more. We caught up with Claude Jones , who is in charge of growing Walmart's technology team in Carlsbad from 70 people and tripling the team, out of new offices it announced this month. How long has Walmart had an office in San Diego?

Xconomy Special Report: 12 San Diego Tech Startup to Watch in 2017

Xconomy

View the Slideshow A little more than a year ago, amid a resurgence in San Diego’s software sector, Xconomy identified a baker’s dozen of local tech companies to watch in 2016. The idea was to feature early stage companies in the region that have not attracted much attention or raised a substantial amount of startup capital. million in a Series D round of investment capital, according to founder and chairman Tony Farwell.

Big VCs Join Xconomy in San Diego to Discuss Big Data, Big Biology

Xconomy

In the Boston office of GE Ventures, managing director Alex de Winter is overseeing investments in companies like Veracyte, which is applying machine learning to genomic sequencing technology to help doctors distinguish benign growths from cancer.

San Diego Startups Raise $287M in Third Quarter, and Top 10 Deals

Xconomy

Venture Capital investments in San Diego startups fell by roughly a third during the three months that ended September 30, according to data released recently by Seattle-based PitchBook and the National Venture Capital Association. VC firms invested $280.6 million in 49 startups in San Diego County during the third quarter, according to a breakout of data provided by PitchBook as part of the inaugural “Venture Monitor” report. San Diego. $35

San Diego VC Funding Hits $547.2M in Q1; Ideaya Leads Top 10 Deals

Xconomy

million into 37 startup companies throughout San Diego County during the first three months of 2018, maintaining roughly the same level of venture funding seen in recent quarters, according to the Venture Monitor Report. The amount of capital invested in the San Diego area was up slightly from the $541.2 million invested during the final three months of 2017, according to Venture Monitor data. million invested in the first quarter last year.

Why 2020 Is Pivotal for Microbiome Drug R&D (Or Maybe 2021, Given COVID-19)

Xconomy

The start of a potentially big biomedical breakthrough is blooming within all of us. Drug research aiming to turn bacteria into microbiome therapies now spans programs aiming to address gut disorders, autism, cancer, and more.

Class 109

First-Quarter Venture Funding Slumps in San Diego, and Top 10 Deals

Xconomy

Thirty-seven venture-backed companies in the San Diego area collected almost $350 million in new funding during the first three months of 2017, according to data released this week as part of the latest Venture Monitor report from the National Venture Capital Association and Seattle-based PitchBook. million that VCs invested in San Diego startups in the same quarter in 2016, and off nearly 17 percent from the $420.3 billion invested.

Q2 VC Funding Soars in San Diego (After Revisions), and Top 10 Deals

Xconomy

After the national MoneyTree Report was released last week, PricewaterhouseCoopers partner Ryan Spencer said he spent time on a call with Thomson Reuters, which provides the raw data, trying to figure out a change in the numbers for venture capital activity in San Diego. San Diego.

Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche’s Protein Play & More

Xconomy

As the nation started to reopen this week following two months of closed businesses and stay-at-home orders, public health officials and economists cautioned that society won’t truly return to anything resembling a pre-pandemic normal without a COVID-19 vaccine.

Study 70

Under New Ownership, San Diego’s Ad-Juster Names Dennis Clerke CEO

Xconomy

Ad-Juster, a San Diego adtech startup acquired earlier this year by the investment arm of China’s Innotech International Group, Wednesday named local software entrepreneur Dennis Clerke as CEO. Clerke (a San Diego Xconomist) was previously the CEO of Sunnyvale, CA-based NetSeer, an adtech acquired in February by Inuvo (NYSE: INUV , an advertising technology and digital publishing company based in Little Rock, AR.

San Diego VC Funding at $426.6M in Third Quarter; Plus Top 10 Deals

Xconomy

The San Diego artificial intelligence company Brain Corp. topped the chart for raising the most venture capital in San Diego during the third quarter that ended September 30, according to Venture Monitor data released Tuesday. Altogether, venture firms invested. As Xconomy reported in July, Brain Corp. raised $114 million in a Series C funding round led by Softbank’s new $100 billion Vision Fund.

Record Exit Value for VC-Backed Startups Could Fuel Investment

Xconomy

billion in money returned to investors—that’s already topped all other full-year totals, according to the latest VentureMonitor, the quarterly report on venture capital investment complied by the National Venture Capital Association and PitchBook.

EvoNexus Gets Bank, Investment Firm Backing for Fintech Incubator

Xconomy

Financial firms are facing competition from legacy players and disruptive fintech startups as technology continues to reshape the heavily regulated industry.

Retro: My Favorite Blog Post on Raising VC

Both Sides of the Table

On December 2nd, 2006 I wrote the blog post published later in this post when I was CEO of startup Koral about my experiences in pitching VCs. After my company was acquired by Salesforce.com I was asked to stop blogging and they took over my blog as an asset in the sale of the company. My blog was wiped out. I had kept a personal blog for more than a year and was new at keeping a professional blog. Remember, I was new to professional blogging.

Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More

Xconomy

Fallout from the spread of COVID-19 infections led several companies to declare this week that they would stop enrolling patients in clinical trials or postpone studies that have not yet started. Finding and enrolling patients for clinical trials is always challenging.

Study 80

At Venture Summit, 3 Takeaways For Entrepreneurs From True Ventures’ Phil Black

Xconomy

No one would argue that San Diego is overflowing with venture capitalists in the way, say, the San Francisco Bay Area is. Venture Summit —an annual gathering of local founders seeking financing and venture investors, primarily from outside San Diego, on the hunt for companies to back—was first organized by the San Diego Venture Group (SDVG) 17 years ago. The idea was to get more local startups an.

Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma’s Path & More

Xconomy

Flagship CEO Noubar Afeyan told Xconomy that the pandemic unexpectedly highlights the need for investment in one of its new thematic areas of interest: “health security” tools and technologies to prevent, detect, and delay disease.

Tool 74

Servier Licenses CureMatch Tech for Custom Cancer Drug Treatments

Xconomy

A global pharmaceutical company based in France has licensed software developed by San Diego digital health startup CureMatch that aims to help cancer doctors customize the combination of drugs they prescribe to patients based on mutations in cancer DNA.

Guide 82

CEOs of Women’s Health Companies Fight to Open Investment Floodgates

Xconomy

EvoFem (NASDAQ: EVFM )—and the rest of the women’s health sector—will know by midyear whether the product will be approved, making the San Diego companies one of the few biotechs to commercialize a novel prescription women’s health product in recent years.

Bio Roundup: Acquisitive Alexion, CRISPR on COVID, C. diff Success & More

Xconomy

It’s a lot to pay for a drug that hasn’t lived up to sales expectations but Hantson. Alexion Pharmacueticals CEO Ludwig Hantson has made no secret that he wants to diversify his company’s drug portfolio and he has shown willingness to open the corporate checkbook to accomplish that goal.

Biotech Roundup: GSK’s Ante, Shakeup at Sage, Telehealth’s Rise & More

Xconomy

The COVID-19 pandemic has stopped enrollment in many clinical trials and postponed the start of others but there is still life in the life sciences sector. Startups are raising money, and there is more financing on the way as investment firms close new funds.

After Investing, GSK to Buy Out Celiac Drug Developer Sitari Pharma

Xconomy

GlaxoSmithKline is acquiring a startup it helped launch in 2013 as part of an alliance with life sciences venture capital firm Avalon Ventures. Sitari was the first of eight companies spun up through the partnership between the Southern California investment outfit and British pharma company.

With Harvard Tech and $5M, PIC Therapeutics Takes Aim at Cancer

Xconomy

PIC Therapeutics is developing medicines aiming for one particularly elusive group of proteins, and the startup’s early research has attracted financial support from some prominent names in the life sciences industry.

Ventus Launches With $60M to Shine Light on Innate Immune System Drugs

Xconomy

Jude Children's Research Hospital startups Teva Pharmaceutical University of California at Berkeley Venture Capital Ventus Therapeutics Versant Ventures Yale UniversityThe innate immune system has become a hot area for drug development, and for good reason.

Tool 70

Flagship Adds $1.1B for New Meds, More AI, & “Health Security”

Xconomy

On Thursday the Cambridge, MA-based venture capital firm, best known for starting and spinning out biotechs, announced it had added $1.1

Bio Roundup: Goodbye Belviq, LogicBio on Hold, Revolution’s IPO & More

Xconomy

Drugs typically go through three phases of clinical testing to support an application for FDA approval. It’s easy to overlook Phase 4, which takes place after a drug reaches the market. Post-marketing studies aim to identify side effects not observed in the first three phases of testing.

Study 69

Roche Pays $190M to Start RNA Drug Alliance With Arrakis Therapeutics

Xconomy

Roche is placing a $190 million bet on Arrakis Therapeutics, a startup whose technology aims for RNA—carriers of the genetic instructions that make these proteins in the first place.

Aspen Neuro Bags $6.5M to Test Parkinson’s Disease Stem Cell Therapy

Xconomy

National blog main San Diego San Diego blog main San Diego top stories Alexandria Venture Investments ARCH Venture Partners Aspen Neuroscience Axon Ventures Biotech Cell Therapy Domain Associates Jeanne Loring Life Sciences Orbimed Parkinson's Disease Section 32 startups Stem Cells

Finistere Plants Investment Seed in Ireland With $24M Agtech Fund

Xconomy

To that end, Kukutai’s venture capital firm, Finistere Ventures, is joining with the Ireland Strategic Investment Fund to launch a new 20 million euro ($24 million) fund that will invest in emerging agtech startups in Ireland. Though Finistere splits its operations between San Diego and Palo Alto, CA, the firm has been expanding its reach globally. Ireland’s top agricultural exports are beef and dairy products.

Empirico Raises $17M, Inks 3-Year Antisense Collaboration with Ionis

Xconomy

Empirico, a biotech that has developed tools to analyze genomics data and use those insights to identify potential therapeutic targets, has signed a collaboration deal with antisense drug developer Ionis Pharmaceuticals that includes a $10 million equity investment.

Beyond Meat’s IPO Bags $241M to Make Plant-Based Burgers Mainstream

Xconomy

deals DNS Venture Partners Ethan Brown Impossible Foods investing IPO Kleiner Perkins Caufield & Byers Kroger Obvious Ventures startups TGI Friday's VC Venture Capital Wegmans Whole Foods Market xperienceA Beyond Meat burger is coming to a location near you—and soon.

AstraZeneca Chooses China for R&D and AI Centers, $1B Biotech Fund

Xconomy

The pharmaceutical giant has also set up a $1 billion fund to foster biotech innovation in that country. AstraZeneca says it will establish centers for drug research and artificial intelligence development in China. The move – which was announced at the China International Import Expo this week – will see the AstraZeneca found a global R&D center in Shanghai’s central Jing’an district.

CEOs of Women’s Health Companies Fight to Open Investment Floodgates

Xconomy

EvoFem (NASDAQ: EVFM )—and the rest of the women’s health sector—will know by midyear whether the product will be approved, making the San Diego companies one of the few biotechs to commercialize a novel prescription women’s health product in recent years.